基本信息
浏览量:0
职业迁徙
个人简介
Over the years, I have developed a strong interest for neuropathological conditions and their mechanisms, and how we could manipulate these molecular mechanisms to develop therapies. I rapidly realised that to understand acute neuropathological conditions such as stroke or chronic brain diseases such as Alzheimer’s disease we must have the ability to study in vivo the mechanisms of such conditions, hence my interest in animal models and in vivo imaging. These neuropathologies are complex and multifactorial, but my interest has focused on inflammation/neuroinflammation due to infection and other comorbidities, as over the last 2 decades they have emerged as major players in brain damage/neuronal loss.
To answer the numerous scientific questions involved in these processes, I have acquired a strong experience in several domains such as pharmacology of various neurotransmission systems (e.g. opioidergic, cholinergic, benzodiazepine), neuroscience, and neuroinflammation and neuropathological conditions such as Alzheimer’s disease or stroke. Over the years, I have become an expert in animal models of stroke and AD (transgenic mice and rats) and most importantly their respective strength and weaknesses (i.e. high reproducibility that translate poorly to clinical application, lack of comorbidities).
I had the opportunity to approach PET imaging during my PhD and I keenly grabbed the opportunity to return to PET imaging during my post-doc in Orsay before bringing that expertise back to Manchester. This technique obviously requires theoretical and practical expertise of the biology it is applied to, but also knowledge in pharmacology, physiology and neuroanatomy, and basic knowledge in radiochemistry to liaise with the radiochemists efficiently. Computing and programming are almost compulsory in this field to enable efficient image analysis, data management and processing which fit quite well with my taste for programming.
Over the years, I have validated several neuroinflammation tracers ([11C]DPA-713, [11C]CLINME, [18F]DPA-714 and [18F]GE-180) that are used in approximately 20 labs worldwide and have generated 170 publications, 55 of them being clinical investigations. My expertise in the field is recognised internationally through my publications, presentations at international conferences with over 50 abstracts accepted as posters or oral presentations and my recent election as president of the European Society for Molecular Imaging.
To answer the numerous scientific questions involved in these processes, I have acquired a strong experience in several domains such as pharmacology of various neurotransmission systems (e.g. opioidergic, cholinergic, benzodiazepine), neuroscience, and neuroinflammation and neuropathological conditions such as Alzheimer’s disease or stroke. Over the years, I have become an expert in animal models of stroke and AD (transgenic mice and rats) and most importantly their respective strength and weaknesses (i.e. high reproducibility that translate poorly to clinical application, lack of comorbidities).
I had the opportunity to approach PET imaging during my PhD and I keenly grabbed the opportunity to return to PET imaging during my post-doc in Orsay before bringing that expertise back to Manchester. This technique obviously requires theoretical and practical expertise of the biology it is applied to, but also knowledge in pharmacology, physiology and neuroanatomy, and basic knowledge in radiochemistry to liaise with the radiochemists efficiently. Computing and programming are almost compulsory in this field to enable efficient image analysis, data management and processing which fit quite well with my taste for programming.
Over the years, I have validated several neuroinflammation tracers ([11C]DPA-713, [11C]CLINME, [18F]DPA-714 and [18F]GE-180) that are used in approximately 20 labs worldwide and have generated 170 publications, 55 of them being clinical investigations. My expertise in the field is recognised internationally through my publications, presentations at international conferences with over 50 abstracts accepted as posters or oral presentations and my recent election as president of the European Society for Molecular Imaging.
研究兴趣
论文共 116 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Acta Biomaterialia (2023): 260-272
引用0浏览0引用
0
0
Acta biomaterialia (2023): 260-272
Theranosticsno. 12 (2022): 5335-5336
bioRxiv (Cold Spring Harbor Laboratory) (2022)
引用0浏览0引用
0
0
Research Square (Research Square) (2022)
biorxiv(2022)
Molecular Imaging and Biologyno. 3 (2022): 596-605
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn